In Vitro Activities of Faropenem against 579 Strains of Anaerobic Bacteria

Wadsworth anaerobic bacteriology manual

1980 • 1,490 citations

Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria

2001 • 316 citations

The Bacteriology of Gangrenous and Perforated Appendicitis—Revisited

1990 • 217 citations

Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae

1996 • 212 citations

Sequencing the gene for an imipenem-cefoxitin-hydrolyzing enzyme (CfiA) from Bacteroides fragilis TAL2480 reveals strong similarity between CfiA and Bacillus cereus beta-lactamase II

1990 • 164 citations

Insertion of a novel DNA sequence, IS 1186, upstream of the silent carbapenemase gene cfiA, promotes expression of carbapenem resistance in clinical isolates of Bacteroides fragilis

1994 • 148 citations

Sutterella wadsworthensis gen. nov., sp. nov., Bile-Resistant Microaerophilic Campylobacter gracilis-Like Clinical Isolates

1996 • 86 citations

The in-vitro activity of faropenem, a novel oral penem

1997 • 57 citations

Susceptibility Patterns and Resistance to Imipenem in the Bacteroides fragilis Group Species in Japan: A 4-Year Study

1993 • 56 citations

Role of Putative Loops 2 and 3 in Imipenem Passage through the Specific Porin OprD of Pseudomonas aeruginosa

2000 • 54 citations

Distribution of the cfiA Gene among Bacteroides fragilis Strains in Japan and Relatedness of cfiA to Imipenem Resistance

1999 • 52 citations

Multiple Mobile Promoter Regions for the Rare Carbapenem Resistance Gene of Bacteroides fragilis

2001 • 51 citations

Expression of the carbapenemase gene (cfiA) in Bacteroides fragilis

2000 • 47 citations

Meropenem Permeation through the Outer Membrane of <i>Pseudomonas aeruginosa</i> Can Involve Pathways Other than the OprD Porin Channel

1996 • 31 citations

Cloning and identification of a two‐component signal‐transducing regulatory system from Bacteroides fragilis

1993 • 28 citations

Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteria

1994 • 25 citations

Mechanisms responsible for reduced susceptibility to imipenem in Bacteroides fragilis

1996 • 21 citations

Comparative in vitro activity of the new oral penem ALP-201 against aerobic and anaerobic bacteria

1989 • 10 citations